{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:48:35Z","timestamp":1791388115947,"version":"4.3.3"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.jns.2005.07.009","type":"journal-article","created":{"date-parts":[[2005,11,11]],"date-time":"2005-11-11T07:14:42Z","timestamp":1131693282000},"page":"37-44","source":"Crossref","is-referenced-by-count":80,"title":["Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA"],"prefix":"10.1016","volume":"239","author":[{"given":"Mark L.","family":"Kuijf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne P.","family":"Tio-Gillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Geleijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Wim","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Hooijkaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim C.J.","family":"Hop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jns.2005.07.009_bib1","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.45.8.1570","article-title":"Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis","volume":"45","author":"van Schaik","year":"1995","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2005.07.009_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1468-1331.1999.610071.x","article-title":"Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies","volume":"6","author":"Willison","year":"1999","journal-title":"Eur J Neurol"},{"issue":"17","key":"10.1016\/j.jns.2005.07.009_bib3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barr\u00e9 syndrome. Dutch Guillain\u2013Barr\u00e9 Study Group","volume":"326","author":"van der Meche","year":"1992","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jns.2005.07.009_bib4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.410350618","article-title":"Treatment of Guillain\u2013Barr\u00e9 syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study","volume":"35","year":"1994","journal-title":"Ann Neurol"},{"issue":"9404","key":"10.1016\/j.jns.2005.07.009_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain\u2013Barr\u00e9 syndrome: randomised trial","volume":"363","author":"van Koningsveld","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jns.2005.07.009_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1212\/WNL.58.4.610","article-title":"Infections and course of disease in mild forms of Guillain\u2013Barr\u00e9 syndrome","volume":"58","author":"Van Koningsveld","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.07.009_bib7","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome","volume":"27 Suppl.","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"10.1016\/j.jns.2005.07.009_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain\u2013Barr\u00e9 syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jns.2005.07.009_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","volume":"124 Suppl.","author":"Brooks","year":"1994","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2005.07.009_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"Campylobacter jejuni infections and anti-GM1 antibodies in Guillain\u2013Barr\u00e9 syndrome","volume":"40","author":"Jacobs","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2005.07.009_bib11","series-title":"Statistical methods","author":"Snedecor","year":"1967"},{"key":"10.1016\/j.jns.2005.07.009_bib12","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/ana.410270714","article-title":"Measurement and clinical importance of antibodies to glycosphingolipids","volume":"27 Suppl.","author":"Marcus","year":"1990","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jns.2005.07.009_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0165-5728(94)90048-5","article-title":"Characterization of anti-ganglioside antibodies present in normal human plasma","volume":"50","author":"Mizutamari","year":"1994","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.jns.2005.07.009_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-5728(96)00029-X","article-title":"Affinity of anti-GM1 antibodies in Guillain\u2013Barr\u00e9 syndrome patients","volume":"66","author":"Deisenhammer","year":"1996","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.jns.2005.07.009_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.410350217","article-title":"The clinical correlates of high-titer IgG anti-GM1 antibodies","volume":"35","author":"Kornberg","year":"1994","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1016\/j.jns.2005.07.009_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0165-5728(94)90237-2","article-title":"Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg)","volume":"54","author":"van Schaik","year":"1994","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.jns.2005.07.009_bib17","first-page":"135","article-title":"Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE","volume":"27","author":"Galeazzi","year":"2000","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jns.2005.07.009_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-5728(94)00129-C","article-title":"Presence and isotype of anti-ganglioside antibodies in healthy persons, motor neuron disease, peripheral neuropathy, and other diseases of the nervous system","volume":"56","author":"Garcia Guijo","year":"1995","journal-title":"J Neuroimmunol"},{"issue":"Pt 12","key":"10.1016\/j.jns.2005.07.009_bib19","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2005.07.009_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1568-9972(03)00089-2","article-title":"Pathogenicity of anti-ganglioside antibodies in the Guillain\u2013Barr\u00e9 syndrome","volume":"3","author":"Van Sorge","year":"2004","journal-title":"Autoimmun Rev"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X05002704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X05002704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T22:23:29Z","timestamp":1548023009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X05002704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0022510X05002704"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2005.07.009","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}